Adverum Biotechnologies Statistics Share Statistics Adverum Biotechnologies has 20.98M
shares outstanding. The number of shares has increased by 0.43%
in one year.
Shares Outstanding 20.98M Shares Change (YoY) 0.43% Shares Change (QoQ) 0.42% Owned by Institutions (%) 73.02% Shares Floating 13.85M Failed to Deliver (FTD) Shares 334 FTD / Avg. Volume 0.19%
Short Selling Information The latest short interest is 998.42K, so 4.76% of the outstanding
shares have been sold short.
Short Interest 998.42K Short % of Shares Out 4.76% Short % of Float 5.42% Short Ratio (days to cover) 9.31
Valuation Ratios The PE ratio is -0.71 and the forward
PE ratio is -2.
Adverum Biotechnologies's PEG ratio is
0.
PE Ratio -0.71 Forward PE -2 PS Ratio 92.38 Forward PS 3.8 PB Ratio 1.31 P/FCF Ratio -0.99 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Adverum Biotechnologies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.73,
with a Debt / Equity ratio of 1.3.
Current Ratio 5.73 Quick Ratio 5.73 Debt / Equity 1.3 Debt / EBITDA -0.72 Debt / FCF -0.99 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $6.45K Profits Per Employee $-844.69K Employee Count 155 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -51.67% in the
last 52 weeks. The beta is 0.92, so Adverum Biotechnologies's
price volatility has been higher than the market average.
Beta 0.92 52-Week Price Change -51.67% 50-Day Moving Average 2.72 200-Day Moving Average 3.7 Relative Strength Index (RSI) 68.21 Average Volume (20 Days) 173,893
Income Statement In the last 12 months, Adverum Biotechnologies had revenue of 1M
and earned -130.93M
in profits. Earnings per share was -6.62.
Revenue 1M Gross Profit -2.65M Operating Income -153.16M Net Income -130.93M EBITDA -127.27M EBIT -130.93M Earnings Per Share (EPS) -6.62
Full Income Statement Balance Sheet The company has 60.65M in cash and 91.7M in
debt, giving a net cash position of -31.05M.
Cash & Cash Equivalents 60.65M Total Debt 91.7M Net Cash -31.05M Retained Earnings -1.07B Total Assets 96.18M Working Capital 17.04M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -92.46M
and capital expenditures -388K, giving a free cash flow of -92.85M.
Operating Cash Flow -92.46M Capital Expenditures -388K Free Cash Flow -92.85M FCF Per Share -4.69
Full Cash Flow Statement Margins Gross margin is -265.3%, with operating and profit margins of -15315.9% and -13092.7%.
Gross Margin -265.3% Operating Margin -15315.9% Pretax Margin -13092.7% Profit Margin -13092.7% EBITDA Margin -12727.4% EBIT Margin -15315.9% FCF Margin -9285%
Dividends & Yields ADVM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ADVM is $21,
which is 505.2% higher than the current price. The consensus rating is "Buy".
Price Target $21 Price Target Difference 505.2% Analyst Consensus Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 21, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Mar 21, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -21.96 Piotroski F-Score 2
